Qyuns Therapeutics Co Ltd Sustainability Reports
The company focuses on the research, development, industrialization, and commercialization of antibody drugs for autoimmune and allergic diseases. It develops clinical-stage biologic pipelines targeting conditions like psoriasis, atopic dermatitis, asthma, and ankylosing spondylitis.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01LXJQNP8
4 reports from 2023 to 2025